Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
  1. 4 Planned sale President & CEO sold 7,500 shares at $6.01 ($45,075)
  2. 4 Planned sale Chief Development Officer sold 49,564 shares at $6.92 ($342,983)
  3. 4 Planned sale President & CEO sold 3,000 shares at $6.07 ($18,210)
  4. 4 Open-market sale Chief Development Officer sold 5,312 shares at $6.26 ($33,254)
  5. 4 Open-market sale President & CEO sold 35,000 shares at $5.61 ($196,399)
  6. 4 Planned sale President & CEO sold 7,500 shares at $6.22 ($46,635)
  7. 4 Open-market sale Chief Medical Officer sold 7,412 shares at $5.86 ($43,437)
  8. 4 Open-market sale Chief Development Officer sold 7,219 shares at $5.86 ($42,306)
  9. 4 Open-market sale Chief Financial Officer sold 5,289 shares at $5.86 ($30,995)
  10. 4 Open-market sale President & CEO sold 32,225 shares at $5.86 ($188,848)
  11. 4 Open-market sale GRAMMER ELIZABETH A sold 7,089 shares at $5.86 ($41,544)
  12. 4 Open-market sale Felsch Robert Ora sold 3,567 shares at $5.86 ($20,904)
  13. 4 Open-market sale Blanks Robert sold 4,969 shares at $5.86 ($29,120)
  14. 4 Planned sale Chief Development Officer sold 40,507 shares at an average $5.97 ($241,782)
  15. 4 Grant or award Chief Commercial Officer acquired 180,000 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Planned sale President & CEO sold 1,229 shares at $5.71 ($7,018)
  18. 4 Planned sale President & CEO sold 30,000 shares at $5.64 ($169,314)
  19. 4 Planned sale President & CEO sold 7,500 shares at $5.97 ($44,768)
  20. 4 Planned sale President & CEO sold 2,310 shares at $6.59 ($15,223)

Page 7 of 35 · 690 filings